T Stamp Inc. Form 8-K Summary
Business Context and Reporting Period
T Stamp Inc. (NASDAQ: IDAI), an emerging growth company, filed this Current Report on December 5, 2024, to disclose the entry into a Material Definitive Agreement. The report details a capital raise executed via a registered direct offering and a concurrent private placement, which closed on December 6, 2024.
Key Financial Metrics and Transaction Details
- Gross Proceeds: Approximately $3.0 million raised from the initial closing of the offering.
- Potential Additional Proceeds: Approximately $5.25 million if all Private Placement Warrants are exercised for cash.
- Securities Issued:
- 2,085,000 shares of Class A Common Stock.
- Pre-Funded Warrants to purchase 3,470,548 shares at $0.001 per share.
- Series A Warrants to purchase up to 5,555,548 shares at $0.54 per share.
- Series B Warrants to purchase up to 4,166,661 shares at $0.54 per share.
- Offering Prices: $0.54 per Share and Private Placement Warrant; $0.539 per Pre-Funded Warrant.
- Transaction Costs: 7.0% cash fee to the placement agent (Maxim Group LLC) plus up to $45,000 in expense reimbursements.
- Use of Proceeds: Working capital, capital expenditures, and general corporate purposes.
Material Changes and Agreements
The filing discloses a significant capital structure change through the issuance of new equity and warrants. Key contractual obligations include:
- Shareholder Approval: The Company must hold a stockholder meeting within 60 days of the closing to approve an increase in authorized shares and the transaction terms. Approval was previously received on November 18, 2024, for the amendment to the certificate of incorporation.
- Registration Rights: The Company must file a registration statement (Form S-1 or similar) within 30 days of the agreement date to register the resale of shares issuable upon exercise of the Private Placement Warrants, with efforts to make it effective within 91 days.
- Lock-Up Agreements: Officers and directors are restricted from selling or hedging securities for 30 days following the closing (until January 5, 2025).
- Issuance Restrictions: The Company is prohibited from issuing common stock or equivalents for 30 days post-closing and from entering variable rate transactions for 45 days post-closing.
Outlook, Risks, and Management Commentary
Management intends to use the net proceeds to support working capital and capital expenditures. The filing includes standard forward-looking statements regarding the Company's ability to maintain its Nasdaq listing and the intended use of proceeds. Specific risks highlighted include:
- Dilution: Significant potential dilution exists if the Pre-Funded Warrants and Private Placement Warrants are exercised.
- Compliance: The transaction is contingent on maintaining Nasdaq listing standards and obtaining necessary shareholder approvals for share authorization.
- Warrant Protections: Series A Warrants include specific protections for the investor in the event of a "Fundamental Transaction" (e.g., merger or asset sale), including potential cash repurchase rights based on Black-Scholes value.
Investor Verification Checklist
- Verify the final net proceeds after deducting the 7% placement fee and other expenses.
- Confirm the date and outcome of the upcoming stockholder meeting required to approve the increase in authorized shares.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.1) for specific covenants and liquidated damages clauses.
- Monitor the filing of the required Form S-1 registration statement for the resale of warrant shares.
- Assess the impact of the new warrant issuance on the Company's fully diluted share count and potential future dilution.